Conference abstract · 14 Jun 2019
Conference abstractPublished 24 Oct 2018
Transformations in global pharmaceutical indutsry
Frost and Sullivan, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The global life sciences industry is witnessing a surge in Chief Executive Officer (CEO) confidence from US tax reforms, turbulent equity markets, and the strengthening global economy. The growth of the life sciences industry is boosted by healthcare digitization and democratization creating an explosion in patient data, the emergence of value based reimbursement models, and healthcare consumerism shifting the risk from payers to providers. The convergence of biopharmaceuticals, drug delivery devices, and companion diagnostics enabled by digital connectivity is driving regulatory and commercial changes in many exciting ways for the industry. In this session hear about Frost and Sullivanâ??s perspective of how business models are changing to maximize growth in life science companies as they embrace the new trends and technology. Key takeaways include top 3 growth opportunities in the biopharmaceutical industry, perspectives from game changing companies on collaborative projects, impact on disruptive technology platforms and best practices for implementing new business models.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 25 Mar 2026
The Role of Effective Project Management Strategies in Transforming Pharmaceuticals Operations during Drug Deliverables
Commentary · 4 Feb 2026
Transforming Drug Development Through Pharmaceutical Biotechnology
Opinion · 28 Mar 2025
The future of medicine: Innovations in synthetic biology transforming pharmaceutics and biomedicine
Article · 18 Feb 2025
The role of digital transformation in enhancing pharmaceutical care services
More from this journal
The newest in Journal of Bioanalysis & Biomedicine.
Article · 29 Dec 2025
Label-Free Biosensing: Revolutionizing Disease Detection and Drug Discovery
Article · 29 Dec 2025
Epigenetic Modifications: Bioanalysis for Disease and Therapeutics
Article · 29 Dec 2025
Advancing Bioanalysis: New Tech, AI, and Precision Medicine
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioanalysis & Biomedicine
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Nitin Naik”

